Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

461. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Friedman M, Serby C W, Menjoge S S, Wilson J D, Hilleman D E, Witek T J Record Status (...) study type Cost-effectiveness analysis. Study population Patients with COPD. Further details are given in the study sample field below. Setting Hospital. The economic study was performed in New Orleans, USA. Dates to which data relate The effectiveness and resource data were collected in 1994. 1998 prices were used. Source of effectiveness data Effectiveness data were based on a single study (based on two multi-centre safety and outcome trials). Link between effectiveness and cost data The costing

1999 NHS Economic Evaluation Database.

462. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. (PubMed)

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. The efficacy of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease (COPD) remains controversial because of a lack of placebo-controlled studies. We compared the effect of inhaled fluticasone propionate with placebo in the treatment of patients with COPD.We used a randomised, double-blind, placebo (...) , respectively). At the end of treatment, patients on fluticasone propionate had increased their 6 min walking distance significantly more than those on placebo (p=0.032). Fluticasone propionate was tolerated as well as placebo, with few adverse effects and without a clinically important effect on mean serum cortisol concentration.Fluticasone propionate may be of clinical benefit in patients with COPD over at least 6 months. Inhaled corticosteroids may have an important role in the long-term treatment

1998 Lancet

463. Revalidatie bij patienten met COPD: een systematische literatuurstudie

Revalidatie bij patienten met COPD: een systematische literatuurstudie Revalidatie bij patienten met COPD: een systematische literatuurstudie Revalidatie bij patienten met COPD: een systematische literatuurstudie Bekkering G E, Cambach W, Hendriks H J, Chadwick-Straver R V, Gosselink R, Jongmans M, Paterson W J, van der Schans C P, Verhoef-de Wijk M C, Decramer M Authors' objectives To assess the efficacy of rehabilitation programmes for patients with chronic obstructive pulmonary disease (COPD (...) ). Searching MEDLINE (from 1982 to current) and the literature files of the Dutch Paramedical Institute (Npi; Physiotherapy Index, Rehabilitation Index and Occupational Index). The following keywords were used (both in English and Dutch): 'CARA', 'COPD', 'chronic bronchitis', 'emphysema', 'RCT', 'clinical trial', 'effect study', 'effectiveness', 'evaluation', 'endurance therapy', 'training', 'movement therapy', 'rehabilitation' and 'physiotherapy'. Bibliographies from retrieved studies were searched

1998 DARE.

464. Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure

Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure Nava S, Evangelisti I, Rampulla C, Compagnoni M L, Fracchia C, Rubini F Record Status This is a critical abstract of an economic (...) . Study population Patients affected by chronic obstructive pulmonary disease (COPD) and acute respiratory failure. The precipitating cause of respiratory failure was respiratory tract infection without radiologic evidence of pneumonia. All the patients were in a hemodynamically stable condition. The need for mechanical ventilation was based on 2 or more of the following: (1) severe dyspnea at rest; (2) PaCO2 greater than 70 mm Hg; (3) pH less than 7.33; (4) arterial oxygen saturation less than 88

1997 NHS Economic Evaluation Database.